Fractyl Health (GUTS) Cash from Investing Activities (2023 - 2025)
Fractyl Health (GUTS) reported Cash from Investing Activities of -$3000.0 for Q4 2025, up 98.71% year-on-year from -$1509.7 in Q4 2024, and up 62.5% quarter-over-quarter from -$8000.0 in Q3 2025.
Fractyl Health (GUTS) has 3 years of Cash from Investing Activities data on file, last reported at -$3000.0 in Q4 2025.
- For the quarter ending Q4 2025, Cash from Investing Activities rose 98.71% year-over-year to -$3000.0; the trailing twelve-month figure through Dec 2025 stood at -$557000.0 (up 68.44% YoY), and the FY2025 full-year result was -$557000.0, up 68.44% from the prior year.
- Cash from Investing Activities for Q4 2025 stood at -$3000.0, up from -$8000.0 in the prior quarter.
- Across five years, Cash from Investing Activities topped out at -$3000.0 in Q4 2025 and bottomed at -$1.1 million in Q1 2024.
- A 3-year average of -$223416.7 and a median of -$142000.0 in 2023 frame the typical range for Cash from Investing Activities.
- Across the five-year window, Cash from Investing Activities tumbled 5195.0% in 2024 and jumped 98.71% in 2025, its largest moves.
- Tracing GUTS's Cash from Investing Activities over 3 years: stood at -$136000.0 in 2023, then sank by 71.32% to -$233000.0 in 2024, then jumped by 98.71% to -$3000.0 in 2025.
- According to Business Quant data, Cash from Investing Activities over the past three periods registered -$3000.0, -$8000.0, and -$98000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - | -2.89 Mn |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | - |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn | 638.50 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn | -431.90 Mn |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn | -428.90 Mn |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn | -25.54 Mn |
| 10 | Fractyl Health | 19.24 Mn | 19.24 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -3,000.00 |
| Dec 31, 2025 | -3,000.00 |
| Sep 30, 2025 | -8,000.00 |
| Sep 30, 2025 | -8,000.00 |
| Jun 30, 2025 | -98,000.00 |
| Jun 30, 2025 | -98,000.00 |
| Mar 31, 2025 | -448,000.00 |
| Mar 31, 2025 | -448,000.00 |
| Dec 31, 2024 | -233,000.00 |
| Dec 31, 2024 | -233,000.00 |
| Sep 30, 2024 | -213,000.00 |
| Sep 30, 2024 | -213,000.00 |
| Jun 30, 2024 | -260,000.00 |
| Jun 30, 2024 | -260,000.00 |
| Mar 31, 2024 | -1.06 Mn |
| Mar 31, 2024 | -1.06 Mn |
| Dec 31, 2023 | -136,000.00 |
| Dec 31, 2023 | -136,000.00 |
| Sep 30, 2023 | -148,000.00 |
| Sep 30, 2023 | -148,000.00 |
| Jun 30, 2023 | -55,000.00 |
| Jun 30, 2023 | -55,000.00 |
| Mar 31, 2023 | -20,000.00 |
| Mar 31, 2023 | -20,000.00 |